Arcus Biosciences Inc
(RCUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,760 | -17,670 | -49,594 | -37,299 | -26,488 |
| Depreciation Amortization | 256 | 206 | 1,912 | 1,700 | 1,743 |
| Accounts receivable | 21 | 83 | -58 | -5,089 | -168 |
| Accounts payable and accrued liabilities | -566 | -517 | -69 | -1,029 | 1,347 |
| Other Working Capital | 4,264 | -1,480 | 1,332 | -2,267 | -122 |
| Other Operating Activity | 5,193 | 2,539 | 3,481 | 8,095 | -436 |
| Operating Cash Flow | $-36,592 | $-16,839 | $-42,996 | $-35,889 | $-24,124 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,131 | 14,907 | -109,697 | -112,466 | -30,256 |
| PPE Investments | -1,179 | -628 | -3,743 | -3,485 | -2,358 |
| Investing Cash Flow | $40,952 | $14,279 | $-113,440 | $-115,951 | $-32,614 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 695 | N/A | 129,209 | 128,438 | 128,445 |
| Common Stock Repurchased | -51 | -5 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -135 | -135 | -135 |
| Financing Cash Flow | $644 | $-5 | $129,074 | $128,303 | $128,310 |
| Beginning Cash Position | 71,267 | 71,267 | 98,629 | 98,629 | 98,629 |
| End Cash Position | 76,271 | 68,702 | 71,267 | 75,092 | 170,201 |
| Net Cash Flow | $5,004 | $-2,565 | $-27,362 | $-23,537 | $71,572 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,592 | -16,839 | -42,996 | -35,889 | -24,124 |
| Capital Expenditure | -1,179 | -628 | -3,743 | -3,485 | -2,358 |
| Free Cash Flow | -37,771 | -17,467 | -46,739 | -39,374 | -26,482 |